Title
Category
Credits
Event date
Cost
AI-Powered Transplant Success: Optimizing Organ Allocation
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This activity will explore the ways in which artificial intelligence (AI) can improve organ allocation and transplantation medicine. This session will delve into how AI-driven algorithms enhance organ-matching precision, help predict transplant outcomes and optimize postoperative care. Participants will gain insight into the practical integration of AI into transplant practices, learn innovative strategies, and discuss real-world examples that demonstrate improved patient care and improve transplant success rates.
The Role of Optometry in the Management of Diabetes
  • Disease management
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will review the role of optometrists in the areas of prevention, co-management and rehabilitation for individuals with diabetes. It will focus on how to conduct a diabetes risk assessment, ongoing care of individuals with known diabetes and collaboration among members of the interprofessional health care team for optimal outcomes. Key strategies for vision rehabilitation will also be addressed.
Heart Failure: Diagnosis and Initial Management for the Primary Care Provider
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
09/17/2025
$0.00
This live webcast is designed to enhance primary care providers’ understanding of the evolving landscape of heart failure classification and treatment. Participants will explore the current nomenclature for heart failure staging and functional classification, with a focus on stratification by ejection fraction. The session will review the latest guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including updates on pharmacologic and device-based interventions. Additionally, common barriers to implementing optimal therapy will be discussed, along with practical strategies to improve adherence and patient outcomes.

Pages